Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Michael

Showing results (931-940 of 1,111) with videos related to

Pageof 112
Sort By:
Retrovirology|October 3, 2014
Aggregate complexes of HIV-1 induced by multimeric antibodiesDaniel J Stieh, Deborah F King, Katja Klein, et al.
AIDS Research and Human Retroviruses|December 24, 2016
Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination RegimensChitraporn Karnasuta, Siriwat Akapirat, Sirinan Madnote, et al.
The Journal of Infectious Diseases|November 19, 2014
HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation LevelsMichael A Eller, Marc S Opollo, Michelle Liu, et al.
Journal of Virology|June 23, 2021
Limited Evidence for a Relationship between HIV-1 Glycan Shield Features in Early Infection and the Development of Neutralization BreadthYifan Li, Hongjun Bai, Eric Sanders-Buell, et al.
Ebiomedicine|January 15, 2021
Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopesTatiana M Garcia-Bates, Mariana L Palma, Renee R Anderko, et al.
Nature Communications|February 22, 2019
Integrated systems approach defines the antiviral pathways conferring protection by the RV144 HIV vaccineSlim Fourati, Susan Pereira Ribeiro, Filipa Blasco Tavares Pereira Lopes, et al.
Elife|September 17, 2021
Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1Shida Shangguan, Philip K Ehrenberg, Aviva Geretz, et al.
Medicine|November 19, 2015
Centralized HIV Program Oversight: An Investigation of a Case Series of New HIV Infections among US Army Soldiers, 2012 to 2013Laura A Pacha, Shilpa Hakre, Otha Myles, et al.
The Journal of Infectious Diseases|February 25, 2016
Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or PolyphosphazeneRobert J O'Connell, Jean-Louis Excler, Victoria R Polonis, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 8, 2022
HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019Hendrik Streeck, Klaus Jansen, Trevor A Crowell, et al.
Pageof 112

Showing results (931-940 of 1,111) with videos related to

Sort By:
Pageof 112
Retrovirology|October 3, 2014
Aggregate complexes of HIV-1 induced by multimeric antibodiesDaniel J Stieh, Deborah F King, Katja Klein, et al.
AIDS Research and Human Retroviruses|December 24, 2016
Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination RegimensChitraporn Karnasuta, Siriwat Akapirat, Sirinan Madnote, et al.
The Journal of Infectious Diseases|November 19, 2014
HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation LevelsMichael A Eller, Marc S Opollo, Michelle Liu, et al.
Journal of Virology|June 23, 2021
Limited Evidence for a Relationship between HIV-1 Glycan Shield Features in Early Infection and the Development of Neutralization BreadthYifan Li, Hongjun Bai, Eric Sanders-Buell, et al.
Ebiomedicine|January 15, 2021
Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopesTatiana M Garcia-Bates, Mariana L Palma, Renee R Anderko, et al.
Nature Communications|February 22, 2019
Integrated systems approach defines the antiviral pathways conferring protection by the RV144 HIV vaccineSlim Fourati, Susan Pereira Ribeiro, Filipa Blasco Tavares Pereira Lopes, et al.
Elife|September 17, 2021
Monocyte-derived transcriptome signature indicates antibody-dependent cellular phagocytosis as a potential mechanism of vaccine-induced protection against HIV-1Shida Shangguan, Philip K Ehrenberg, Aviva Geretz, et al.
Medicine|November 19, 2015
Centralized HIV Program Oversight: An Investigation of a Case Series of New HIV Infections among US Army Soldiers, 2012 to 2013Laura A Pacha, Shilpa Hakre, Otha Myles, et al.
The Journal of Infectious Diseases|February 25, 2016
Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or PolyphosphazeneRobert J O'Connell, Jean-Louis Excler, Victoria R Polonis, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 8, 2022
HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019Hendrik Streeck, Klaus Jansen, Trevor A Crowell, et al.
Pageof 112